Tomas Neilan

18PUBLICATIONS
165CO-AUTHORS
Cancer cell biologyImmunogenetics (incl. genetic immunology)Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Nov 26, 2025
Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer.

Giselle Alexandra Suero-Abreu, Zsofia D Drobni, Carlos A Gongora

|Jul 04, 2025
Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.

Nikhil Dubey, Chia-Yun Wu, Leyre Zubiri

|Mar 27, 2025
Associations Between Social Determinants of Health, Allostatic Load, and Anthracycline Cardiotoxicity in a Diverse Patient Population.

Lili Zhang, Justin Song, Waqas Hanif

|Mar 19, 2025
Racial and Ethnic Disparities in Cardiotoxicity in Patients With Cancer Treated With Anthracyclines.

Lili Zhang, Justin Song, Waqas Hanif

|Mar 11, 2025
Immune checkpoint inhibitors and myocardial infarction.

Vencel Juhasz, Giselle Alexandra Suero-Abreu, Tomas G Neilan

|Sep 03, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.

Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic

Pageof 3